Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Hamer

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Gait & Posture|December 7, 2010
Lycra(®) arm splints improve movement fluency in children with cerebral palsyCatherine Elliott, Siobhan Reid, Peter Hamer, et al.
The New Zealand Medical Journal|March 26, 2021
Can patient symptoms reliably predict major oesophageal motility disorders assessed by conventional water perfusion manometry?Conrad Stranz, Thomas Watkinson, Andrea Cross, et al.
Australian and New Zealand Journal of Public Health|November 5, 2002
Sports injury experiences from the Western Australian Sports Injury Cohort StudyCaroline Finch, Annette Da Costa, Mark Stevenson, et al.
Plos One|January 4, 2013
The recovery of repeated-sprint exercise is associated with PCr resynthesis, while muscle pH and EMG amplitude remain depressedAlberto Mendez-Villanueva, Johann Edge, Rob Suriano, et al.
Burns : Journal of the International Society for Burn Injuries|May 15, 2013
Grip strength dynamometry: reliability and validity for adults with upper limb burnsMerci S Clifford, Peter Hamer, Michael Phillips, et al.
Cancer|April 5, 2007
Elevated plasma tissue inhibitor of metalloproteinase-1 level predicts decreased response and survival in metastatic breast cancerAllan Lipton, Suhail M Ali, Kim Leitzel, et al.
Cancer|October 19, 2006
Serum epidermal growth factor receptor/HER-2 predicts poor survival in patients with metastatic breast cancerChristopher Souder, Kim Leitzel, Suhail M Ali, et al.
Leukemia Research|September 29, 2009
High levels of serum TIMP-1 correlate with advanced disease and predict for poor survival in patients with multiple myeloma treated with novel agentsEvangelos Terpos, Meletios A Dimopoulos, Vikas Shrivastava, et al.
Cancer|June 14, 2005
Serum HER-2/neu conversion to positive at the time of disease progression in patients with breast carcinoma on hormone therapyAllan Lipton, Kim Leitzel, Suhail M Ali, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2008
Serum TIMP-1 and response to the aromatase inhibitor letrozole versus tamoxifen in metastatic breast cancerAllan Lipton, Kim Leitzel, Hilary A Chaudri-Ross, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Gait & Posture|December 7, 2010
Lycra(®) arm splints improve movement fluency in children with cerebral palsyCatherine Elliott, Siobhan Reid, Peter Hamer, et al.
The New Zealand Medical Journal|March 26, 2021
Can patient symptoms reliably predict major oesophageal motility disorders assessed by conventional water perfusion manometry?Conrad Stranz, Thomas Watkinson, Andrea Cross, et al.
Australian and New Zealand Journal of Public Health|November 5, 2002
Sports injury experiences from the Western Australian Sports Injury Cohort StudyCaroline Finch, Annette Da Costa, Mark Stevenson, et al.
Plos One|January 4, 2013
The recovery of repeated-sprint exercise is associated with PCr resynthesis, while muscle pH and EMG amplitude remain depressedAlberto Mendez-Villanueva, Johann Edge, Rob Suriano, et al.
Burns : Journal of the International Society for Burn Injuries|May 15, 2013
Grip strength dynamometry: reliability and validity for adults with upper limb burnsMerci S Clifford, Peter Hamer, Michael Phillips, et al.
Cancer|April 5, 2007
Elevated plasma tissue inhibitor of metalloproteinase-1 level predicts decreased response and survival in metastatic breast cancerAllan Lipton, Suhail M Ali, Kim Leitzel, et al.
Cancer|October 19, 2006
Serum epidermal growth factor receptor/HER-2 predicts poor survival in patients with metastatic breast cancerChristopher Souder, Kim Leitzel, Suhail M Ali, et al.
Leukemia Research|September 29, 2009
High levels of serum TIMP-1 correlate with advanced disease and predict for poor survival in patients with multiple myeloma treated with novel agentsEvangelos Terpos, Meletios A Dimopoulos, Vikas Shrivastava, et al.
Cancer|June 14, 2005
Serum HER-2/neu conversion to positive at the time of disease progression in patients with breast carcinoma on hormone therapyAllan Lipton, Kim Leitzel, Suhail M Ali, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2008
Serum TIMP-1 and response to the aromatase inhibitor letrozole versus tamoxifen in metastatic breast cancerAllan Lipton, Kim Leitzel, Hilary A Chaudri-Ross, et al.
Pageof 3